ATOM insider files Form 144 to sell 3,979 shares

ATOM filed a Form 144 reporting an intended sale of 3,979 common shares associated with the vesting of restricted stock granted under the issuer's equity compensation plan.

Accepted by SEC EDGAR 03/02/2026 - 09:02 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

ATOM filed a Form 144 reporting an intended sale of 3,979 common shares associated with the vesting of restricted stock granted under the issuer's equity compensation plan. The vesting event is dated 03/01/2026 and the filing is dated 03/02/2026. The transaction lists Morgan Stanley Smith Barney LLC as the broker and indicates NASDAQ as the market.

Insights

Securities Counsel

Form 144 notifies the market of a planned resale of vested restricted shares by an insider.

The filing documents an intended resale of 3,979 common shares that vested on 03/01/2026, with the broker identified as Morgan Stanley Smith Barney LLC and the market as NASDAQ. The shares were granted under the issuer's equity compensation plan.

Because this is a routine resale notice tied to vesting, the practical impact depends on whether and when the holder executes sales; subsequent SEC filings would show actual sales and proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ATOM's Form 144 report?

It reports an intended resale of 3,979 common shares. The shares vested on 03/01/2026 under the issuer's equity compensation plan and the Form 144 was filed on 03/02/2026 with Morgan Stanley Smith Barney LLC named as broker.

Were the shares from an equity grant or open-market purchase (ATOM)?

The shares arose from a restricted stock grant. The filing states the shares were "granted as part of issuer's equity compensation plan" and that the sale is tied to a vesting event dated 03/01/2026.

How many ATOM shares are included in the Form 144?

The Form 144 lists 3,979 common shares. That quantity is shown alongside the vesting date 03/01/2026 and the filing date 03/02/2026; further filings would show whether and when these shares are actually sold.

Which broker and market are named in ATOM's Form 144?

Broker: Morgan Stanley Smith Barney LLC; Market: NASDAQ. Both are listed in the filing alongside the share count and dates, indicating the intended channel for any resale activity reported on the Form 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001680617
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Atomera, Inc.
SEC File Number	001-37850
Address of Issuer	750 University Avenue, Suite 280 Los Gatos CALIFORNIA 95032
Phone	408-442-5248
Name of Person for Whose Account the Securities are To Be Sold	Robert Mears
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	CTO

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3979	19690.04	38696147	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2026	Vesting of Restricted Stock	Issuer			3979	03/02/2026	Granted as part of issuer's equity compensation plan.

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The shares are being sold pursuant to "sell to cover" transactions under four separate compensatory equity awards with distinct grant dates of 2/23/22, 2/23/23, 2/21/24 and 2/19/25. Each award agreement includes a provision for non-discretionary "sell-to-cover transactions" pursuant to Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act and each award is intended to operate as a "Rule 10b5-1 trading arrangement" as the term is defined in Item 408(a) of Regulation S-K.
Date of Notice	03/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Robert Mears
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)